Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP496220.RADSqmxbkVnbWScrOUKpEf8mUOa3O3O3KERKa4XSwNspk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP496220.RADSqmxbkVnbWScrOUKpEf8mUOa3O3O3KERKa4XSwNspk130_assertion type Assertion NP496220.RADSqmxbkVnbWScrOUKpEf8mUOa3O3O3KERKa4XSwNspk130_head.
- NP496220.RADSqmxbkVnbWScrOUKpEf8mUOa3O3O3KERKa4XSwNspk130_assertion description "[We previously demonstrated that mucosal Hsp60 decreases in UC patients treated with conventional therapies (mesalazine, probiotics), suggesting that this chaperonin could be a reliable biomarker useful for monitoring response to treatment, and that it might play a role in pathogenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP496220.RADSqmxbkVnbWScrOUKpEf8mUOa3O3O3KERKa4XSwNspk130_provenance.
- NP496220.RADSqmxbkVnbWScrOUKpEf8mUOa3O3O3KERKa4XSwNspk130_assertion evidence source_evidence_literature NP496220.RADSqmxbkVnbWScrOUKpEf8mUOa3O3O3KERKa4XSwNspk130_provenance.
- NP496220.RADSqmxbkVnbWScrOUKpEf8mUOa3O3O3KERKa4XSwNspk130_assertion SIO_000772 22297444 NP496220.RADSqmxbkVnbWScrOUKpEf8mUOa3O3O3KERKa4XSwNspk130_provenance.
- NP496220.RADSqmxbkVnbWScrOUKpEf8mUOa3O3O3KERKa4XSwNspk130_assertion wasDerivedFrom befree-20140225 NP496220.RADSqmxbkVnbWScrOUKpEf8mUOa3O3O3KERKa4XSwNspk130_provenance.
- NP496220.RADSqmxbkVnbWScrOUKpEf8mUOa3O3O3KERKa4XSwNspk130_assertion wasGeneratedBy ECO_0000203 NP496220.RADSqmxbkVnbWScrOUKpEf8mUOa3O3O3KERKa4XSwNspk130_provenance.